Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 73

1.

Regulatory T cells: a possible promising approach to cancer recurrence induced by morphine.

Gong L, Dong C, Ouyang W, Qin Q.

Med Hypotheses. 2013 Mar;80(3):308-10. doi: 10.1016/j.mehy.2012.12.013.

PMID:
23313332
2.

Tumor-infiltrating lymphocytes, tumor characteristics, and recurrence in patients with early breast cancer.

Kim ST, Jeong H, Woo OH, Seo JH, Kim A, Lee ES, Shin SW, Kim YH, Kim JS, Park KH.

Am J Clin Oncol. 2013 Jun;36(3):224-31. doi: 10.1097/COC.0b013e3182467d90.

PMID:
22495453
3.

The contribution of vascular endothelial growth factor to the induction of regulatory T-cells in malignant effusions.

Wada J, Suzuki H, Fuchino R, Yamasaki A, Nagai S, Yanai K, Koga K, Nakamura M, Tanaka M, Morisaki T, Katano M.

Anticancer Res. 2009 Mar;29(3):881-8.

4.
5.

The role of morphine in regulation of cancer cell growth.

Gach K, Wyrębska A, Fichna J, Janecka A.

Naunyn Schmiedebergs Arch Pharmacol. 2011 Sep;384(3):221-30. doi: 10.1007/s00210-011-0672-4. Review.

6.

Systemic and local characterization of regulatory T cells in a chronic fungal infection in humans.

Cavassani KA, Campanelli AP, Moreira AP, Vancim JO, Vitali LH, Mamede RC, Martinez R, Silva JS.

J Immunol. 2006 Nov 1;177(9):5811-8.

7.

The role of regulatory T lymphocytes in the induced immune response mediated by biological vaccines.

López M, Aguilera R, Pérez C, Mendoza-Naranjo A, Pereda C, Ramirez M, Ferrada C, Aguillón JC, Salazar-Onfray F.

Immunobiology. 2006;211(1-2):127-36. Review.

PMID:
16446177
8.

[Detection of intracellular and extracellular cytokines of CD4+CD25+ regulatory T cells in gastric cancer patients].

Wang LY, Zeng Y, Pan ZZ, Zhu ZH.

Ai Zheng. 2007 Mar;26(3):270-3. Chinese.

PMID:
17355789
9.

Tumor evasion of the immune system by converting CD4+CD25- T cells into CD4+CD25+ T regulatory cells: role of tumor-derived TGF-beta.

Liu VC, Wong LY, Jang T, Shah AH, Park I, Yang X, Zhang Q, Lonning S, Teicher BA, Lee C.

J Immunol. 2007 Mar 1;178(5):2883-92.

10.

Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).

Pergolizzi J, Böger RH, Budd K, Dahan A, Erdine S, Hans G, Kress HG, Langford R, Likar R, Raffa RB, Sacerdote P.

Pain Pract. 2008 Jul-Aug;8(4):287-313. doi: 10.1111/j.1533-2500.2008.00204.x.

PMID:
18503626
11.

[Regulatory T cells].

Marinić I, Gagro A, Rabatić S.

Acta Med Croatica. 2006 Dec;60(5):447-56. Review. Croatian.

PMID:
17217101
12.

Cooperation of liver cells in health and disease.

Kmieć Z.

Adv Anat Embryol Cell Biol. 2001;161:III-XIII, 1-151. Review.

PMID:
11729749
14.

Mesothelioma environment comprises cytokines and T-regulatory cells that suppress immune responses.

Hegmans JP, Hemmes A, Hammad H, Boon L, Hoogsteden HC, Lambrecht BN.

Eur Respir J. 2006 Jun;27(6):1086-95.

15.

The characterization and role of regulatory T cells in immune reactions.

Wilczynski JR, Radwan M, Kalinka J.

Front Biosci. 2008 Jan 1;13:2266-74. Review.

PMID:
17981708
16.
17.

Utility of tumour-infiltrating CD25+FOXP3+ regulatory T cell evaluation in predicting local recurrence in vertical growth phase cutaneous melanoma.

Miracco C, Mourmouras V, Biagioli M, Rubegni P, Mannucci S, Monciatti I, Cosci E, Tosi P, Luzi P.

Oncol Rep. 2007 Nov;18(5):1115-22.

PMID:
17914561
18.

Identification of CD8+CD25+Foxp3+ suppressive T cells in colorectal cancer tissue.

Chaput N, Louafi S, Bardier A, Charlotte F, Vaillant JC, Ménégaux F, Rosenzwajg M, Lemoine F, Klatzmann D, Taieb J.

Gut. 2009 Apr;58(4):520-9. doi: 10.1136/gut.2008.158824.

PMID:
19022917
19.
20.

The impact of CD4+CD25+ Treg on tumor specific CD8+ T cell cytotoxicity and cancer.

Khazaie K, von Boehmer H.

Semin Cancer Biol. 2006 Apr;16(2):124-36. Review.

PMID:
16443370

Supplemental Content

Support Center